Abstract
Background Monkeypox virus re-surged in May 2022 as a new potential global health threat with outbreaks bursting in multiple countries across different continents. This study was conducted during the first month of the WHO announcement to assess the healthcare workers (HCWs) within Saudi Arabia, exploring their perception, worries, and vaccine acceptance for Monkeypox in-line with the resolving COVID-19 pandemic.
Methods A national cross-sectional survey was conducted between May 27 and June 10, 2022, in Saudi Arabia. Data were collected on the sociodemographic and job-related characteristics, COVID-19 infection status, HCWs’ worry levels of Monkeypox compared to COVID-19 and its sources, their perceptions, awareness, and HCWs’ Monkeypox vaccination advocacy.
Results Among the 1130 HCWs who completed survey, 41.6% already developed COVID-19. Still, 56.5% were more worried from COVID-19 compared to Monkeypox, while the rest were more worried of Monkeypox disease. The main reason for their worry among 68.8% of the participants was development of another worldwide pandemic post COVID-19, followed by their worry of acquiring the infection themselves or their families (49.6%). Most HCWs (60%) rated their self-awareness of Monkeypox disease as moderate to high.
Males and those who previously developed COVID-19 were significantly less likely to worry about Monkeypox. The worry about Monkeypox developing into a pandemic and the perception of Monkeypox being a severe disease correlated significantly positively with the odds of high worry from the disease.
Regarding participants’ advocacy for HCWs’ vaccination against Monkeypox disease, those who developed COVID-19 previously and those who supported application of tighter infection control measures compared to the current ones to combat the disease were significantly predicted to agree for vaccination. 74.2% of the surveyed HCWs perceived that they need to read more about the Monkeypox disease after the survey.
Conclusion During the first month of the WHO’s Monkeypox international alert, about half of HCWs in this study were more worried about Monkeypox disease as compared to COVID-19, and its possible progression into another pandemic. In addition, the majority were in favor of applying tighter infection prevention measures to combat the disease. The current study highlights areas needed for healthcare administrative about the HCWs’ perceptions and readiness for Monkeypox especially in the event of any occurrence of local or international pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of King Saud University gave ethical approval for this work (approval 22/0416/IRB)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author emails and ORCID IDs:
1. Fadi Aljamaan faljamaan{at}ksu.edu.sa
2. Shuliweeh Alenezi: salenizi{at}ksu.edu.sa
3. Khalid Alhasan: kalhasan{at}ksu.edu.sa
4. Basema Saddik Bsaddik{at}sharjah.ac.ae
5. Ali Alhaboob drhbooob{at}gmail.com
6. Esraa S. Altawil etaweel{at}live.com ealtawil{at}KSU.EDU.SA
7. Fatimah Alshahrani Falshahrani1{at}ksu.edu.sa
8. Abdulkarim Alrabiaah alrabiaah{at}KSU.EDU.SA
9. Ali Alaraj al_araj{at}hotmail.com
10. Khaled Alkriadees kalkriadees{at}KSU.EDU.SA
11. Yousef Alsahamlan yalshamlani{at}KSU.EDU.SA
12. Homood Alharbi homalharbi{at}KSU.EDU.SA
13. Amr Jamal amrjamal{at}ksu.edu.sa
14. Rabih Halwani: rhalwani{at}sharjah.ac.ae
15. Fahad AlZamil fzamil{at}KSU.EDU.SA
16. Sarah Al-Subaie salsubaie{at}ksu.edu.sa
17. Mazin Barry mbarry{at}ksu.edu.sa
18. Ziad A Memish zmemish{at}yahoo.com
19. Jaffar A. Al-Tawfiq jaltawfi{at}yahoo.com
20. Mohamad-Hani Temsah mtemsah{at}ksu.edu.sa
Conflict of interest: None declared.
Ethics approval and consent to participate: The study was approved by the institutional review board of King Saud University (approval 22/0416/IRB).
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
Abbreviations
- CDC
- Centers for Disease Control and Prevention
- COVID-19
- Coronavirus disease 2019
- MOH
- Ministry of Health
- MOXV
- Monkeypox virus
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- WHO
- World Health Organization